Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Showing news for:SHILPAMED
Clear all filters
neutral
Moneycontrol NaNd ago
Shilpa Medicare enters monetisation phase, after years of investments R&D, manufacturing
According to India Ratings & Research, Shilpa has spent over Rs. 800 crore on R&D expenses during FY21-FY25, with capex of over Rs. 1,200 crore. Shilpa spends around 8 percent of its annual revenue on R&D.
SHILPAMEDHealthcare